Health Catalyst Stock Probability of Future Stock Price Finishing Under 5.58

HCAT Stock  USD 6.54  0.23  3.65%   
Health Catalyst's implied volatility is one of the determining factors in the pricing options written on Health Catalyst. Implied volatility approximates the future value of Health Catalyst based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Health Catalyst over a specific time period. For example, 2024-05-17 CALL at $7.5 is a CALL option contract on Health Catalyst's common stock with a strick price of 7.5 expiring on 2024-05-17. The contract was last traded on 2024-05-01 at 15:00:31 for $0.05 and, as of today, has 15 days remaining before the expiration. The option is currently trading at a bid price of $0.15, and an ask price of $0.2. The implied volatility as of the 3rd of May is 94.34. View All Health options

Closest to current price Health long CALL Option Payoff at Expiration

Health Catalyst's future price is the expected price of Health Catalyst instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Health Catalyst performance during a given time horizon utilizing its historical volatility. Check out Health Catalyst Backtesting, Health Catalyst Valuation, Health Catalyst Correlation, Health Catalyst Hype Analysis, Health Catalyst Volatility, Health Catalyst History as well as Health Catalyst Performance.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.
  
Price Earnings To Growth Ratio is likely to gain to 0.25 in 2024, whereas Price To Sales Ratio is likely to drop 1.68 in 2024. Please specify Health Catalyst's target price for which you would like Health Catalyst odds to be computed.

Health Catalyst Target Price Odds to finish below 5.58

The tendency of Health Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 5.58  or more in 90 days
 6.54 90 days 5.58 
about 6.43
Based on a normal probability distribution, the odds of Health Catalyst to drop to $ 5.58  or more in 90 days from now is about 6.43 (This Health Catalyst probability density function shows the probability of Health Stock to fall within a particular range of prices over 90 days) . Probability of Health Catalyst price to stay between $ 5.58  and its current price of $6.54 at the end of the 90-day period is about 12.92 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.12 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Health Catalyst will likely underperform. Additionally Health Catalyst has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Health Catalyst Price Density   
       Price  

Predictive Modules for Health Catalyst

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Health Catalyst. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Health Catalyst's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
2.736.4910.25
Details
Intrinsic
Valuation
LowRealHigh
4.788.5412.30
Details
Naive
Forecast
LowNextHigh
3.547.3011.06
Details
17 Analysts
Consensus
LowTargetHigh
13.3514.6716.28
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Health Catalyst. Your research has to be compared to or analyzed against Health Catalyst's peers to derive any actionable benefits. When done correctly, Health Catalyst's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Health Catalyst.

Health Catalyst Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Health Catalyst is not an exception. The market had few large corrections towards the Health Catalyst's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Health Catalyst, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Health Catalyst within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.72
β
Beta against NYSE Composite2.12
σ
Overall volatility
1.47
Ir
Information ratio -0.18

Health Catalyst Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Health Catalyst for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Health Catalyst can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Health Catalyst generated a negative expected return over the last 90 days
Health Catalyst has high historical volatility and very poor performance
Health Catalyst has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 295.94 M. Net Loss for the year was (118.15 M) with profit before overhead, payroll, taxes, and interest of 135.56 M.
Health Catalyst currently holds about 403.35 M in cash with (33.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from forbes.com: New Recommendation

Health Catalyst Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Health Stock often depends not only on the future outlook of the current and potential Health Catalyst's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Health Catalyst's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding56.4 M
Cash And Short Term Investments317.7 M

Health Catalyst Technical Analysis

Health Catalyst's future price can be derived by breaking down and analyzing its technical indicators over time. Health Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Health Catalyst. In general, you should focus on analyzing Health Stock price patterns and their correlations with different microeconomic environments and drivers.

Health Catalyst Predictive Forecast Models

Health Catalyst's time-series forecasting models is one of many Health Catalyst's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Health Catalyst's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Health Catalyst

Checking the ongoing alerts about Health Catalyst for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Health Catalyst help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Health Catalyst generated a negative expected return over the last 90 days
Health Catalyst has high historical volatility and very poor performance
Health Catalyst has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 295.94 M. Net Loss for the year was (118.15 M) with profit before overhead, payroll, taxes, and interest of 135.56 M.
Health Catalyst currently holds about 403.35 M in cash with (33.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.37, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from forbes.com: New Recommendation
When determining whether Health Catalyst is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Health Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Health Catalyst Stock. Highlighted below are key reports to facilitate an investment decision about Health Catalyst Stock:
Check out Health Catalyst Backtesting, Health Catalyst Valuation, Health Catalyst Correlation, Health Catalyst Hype Analysis, Health Catalyst Volatility, Health Catalyst History as well as Health Catalyst Performance.
For more information on how to buy Health Stock please use our How to Invest in Health Catalyst guide.
Note that the Health Catalyst information on this page should be used as a complementary analysis to other Health Catalyst's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Health Stock analysis

When running Health Catalyst's price analysis, check to measure Health Catalyst's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health Catalyst is operating at the current time. Most of Health Catalyst's value examination focuses on studying past and present price action to predict the probability of Health Catalyst's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health Catalyst's price. Additionally, you may evaluate how the addition of Health Catalyst to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Health Catalyst's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Health Catalyst. If investors know Health will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Health Catalyst listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.09)
Revenue Per Share
5.245
Quarterly Revenue Growth
0.086
Return On Assets
(0.07)
Return On Equity
(0.30)
The market value of Health Catalyst is measured differently than its book value, which is the value of Health that is recorded on the company's balance sheet. Investors also form their own opinion of Health Catalyst's value that differs from its market value or its book value, called intrinsic value, which is Health Catalyst's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Health Catalyst's market value can be influenced by many factors that don't directly affect Health Catalyst's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Health Catalyst's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Catalyst is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Catalyst's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.